Organization · Venture Capital
HERAN Partners
HERAN Partners is a venture capital firm based in Antwerp, Belgium, focusing on seed and early-stage investments in the healthcare and life sciences sectors across Europe. The firm aims to drive innovation in MedTech, HealthTech, and Digital Health.
Overview
What HERAN Partners does
What HERAN Partners is
HERAN Partners is a venture capital firm based in Antwerp, Belgium, focusing on seed and early-stage investments in the healthcare and life sciences sectors across Europe. The firm aims to drive innovation in MedTech, HealthTech, and Digital Health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find HERAN Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
HERAN Partners as a funder
Investment thesis
HERAN Partners focuses on seed and Series A investments in life sciences, MedTech, and digital health, targeting innovative solutions that address real-world clinical problems.
Focus narrative
Heran Partners invests in companies that demonstrate feasibility for disruptive innovation in healthcare and life sciences. They focus on solutions that address unmet market needs, targeting investments in hardware, software, and services that enhance patient care and improve efficiency in drug development. Their investment strategy encompasses seed, Series A, and Series B stages.
Value beyond capital
Heran Partners adds value to its portfolio companies through mentorship and access to a robust network of industry experts. They focus on supporting bold innovators with differentiated approaches built on solid intellectual property and know-how, enhancing their potential for success in the healthcare market.
Terms and economics
- Typical check
- $1,000,000–$6,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- EuropeUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 14
- Recorded notable exits
- icometrix, UgenTec, PharmaFluidics, and BlueBee
Portfolio context
Notable portfolio companies include: Pharmacelera: Develops in-silico drug discovery technologies for biotech and pharmaceutical companies. Gynaia: A women's health diagnostics company providing AI tools for gynecological professionals. Nuclivision: Develops software solutions for nuclear imaging to enhance clinical workflow. ImmuneSpec: Focuses on immunogenicity testing through proprietary assays. Aspect Analytics: Provides bioinformatics software for spatial omics in pharmaceutical research. Amaron: A healthcare software connector standardizing data structures across hospital tools. Thirona: Specializes in AI-assisted medical image analysis. Hypervision Surgical: Uses AI to enhance surgical outcomes. Broken String Biosciences: Develops safer cell and gene therapies. icometrix: Analyzes brain MRI and CT scans for neurological conditions.
Common questions
What to know about HERAN Partners
Upseed classifies HERAN Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.